Ursula Kirchmayer, FISPE
Pharmacoepidemiologist
Department of Epidemiology, ASL Roma1,
Lazio Regional Health Service
Rome, Italy

Fredrik Nyberg, FISPE
Professor of Register Epidemiology
School of Public Health and Community Medicine,
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg
Gothenburg, Sweden

Lisa Pont, FISPE
Associate Professor & Team Lead Medicines Use Research in
Aged Care (MURAC)
Discipline of Pharmacy, Graduate School of Health
University of Technology Sydney (UTS)
Sydney, Australia

Jennita Reefhuis
Branch Chief, Birth Defects Branch
National Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention
Atlanta, USA

Mary Beth Ritchey, FISPE 
Principal & Owner, Med Tech Epi, LLC, Philadelphia, PA, USA
Associate Research Professor, Center for Pharmacoepidemiology and Treatment Sciences, Rutgers University, New Brunswick, NJ, USA

Tomoko Kobayashi
Epidemiologist, Real World Evidence, Science & Data Analytics Division, Research & Development, Astrazeneca K.K.
Osaka, Japan

Mette Nørgaard
Professor in Epidemiology of Urinary Tract Diseases, Department of Clinical Epidemiology
Aarhus University
Denmark

Jeremy Rassen, FISPE
Co-Founder, President and Chief Science Officer at Aetion, Inc.,
New York, NY

Montse Soriano Gabarro, FISPE
Head of Epidemiology
Bayer AG
Berlin, Germany

Shirley Wang, FISPE
Assistant Professor, Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital
Harvard Medical School
Boston, USA

Jennifer Lund, FISPE
Associate Professor, Department of Epidemiology
University of North Carolina at Chapel Hill
Chapel Hill, USA

Stine Hasling Mogensen
Senior Advisor
Danish Medicines Agency's Data Analytic Centre
Copenhagen, Denmark

Daniel Prieto-Alhambra, FISPE
Professor of Pharmaco- and Device Epidemiology
Centre for Statistics in Medicine
Oxford, UK

Yoshiaki Uyama
Director, Office of Medical Informatics and Epidemiology
Pharmaceuticals and Medical Devices Agency (PMDA)
Tokyo, Japan

Hongbo Yuan
Scientific Advisor, Evidence Standard
Canadian Agency for Drugs and Technologies in Health
Ottawa, Canada

Stanley A. Edlavitch, FISPE
University of Missouri School of Medicine
Kansas City, USA